MX2016000099A - Vacunas sinteticas contra streptococcus pneumoniae tipo 1. - Google Patents
Vacunas sinteticas contra streptococcus pneumoniae tipo 1.Info
- Publication number
- MX2016000099A MX2016000099A MX2016000099A MX2016000099A MX2016000099A MX 2016000099 A MX2016000099 A MX 2016000099A MX 2016000099 A MX2016000099 A MX 2016000099A MX 2016000099 A MX2016000099 A MX 2016000099A MX 2016000099 A MX2016000099 A MX 2016000099A
- Authority
- MX
- Mexico
- Prior art keywords
- streptococcus pneumoniae
- vaccines against
- pneumoniae type
- against streptococcus
- synthetic vaccines
- Prior art date
Links
- 241000193998 Streptococcus pneumoniae Species 0.000 title abstract 3
- 229940031000 streptococcus pneumoniae Drugs 0.000 title abstract 3
- 229940126577 synthetic vaccine Drugs 0.000 title 1
- 150000001720 carbohydrates Chemical group 0.000 abstract 3
- 150000004676 glycans Chemical class 0.000 abstract 2
- 229920001282 polysaccharide Polymers 0.000 abstract 2
- 239000005017 polysaccharide Substances 0.000 abstract 2
- 238000006257 total synthesis reaction Methods 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56944—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/315—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Streptococcus (G), e.g. Enterococci
- G01N2333/3156—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae [Pneumococcus]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Mycology (AREA)
- Physics & Mathematics (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Oncology (AREA)
- Orthopedic Medicine & Surgery (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13175447 | 2013-07-07 | ||
| EP13183826.0A EP2845860A1 (en) | 2013-09-10 | 2013-09-10 | Synthetic vaccines against Streptococcus pneumoniae |
| EP13196568 | 2013-12-10 | ||
| PCT/EP2014/064407 WO2015004041A1 (en) | 2013-07-07 | 2014-07-07 | Synthetic vaccines against streptococcus pneumoniae type 1 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2016000099A true MX2016000099A (es) | 2016-07-07 |
Family
ID=51257468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016000099A MX2016000099A (es) | 2013-07-07 | 2014-07-07 | Vacunas sinteticas contra streptococcus pneumoniae tipo 1. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US10328141B2 (enExample) |
| EP (1) | EP3019513B1 (enExample) |
| JP (1) | JP6416249B2 (enExample) |
| KR (1) | KR102250099B1 (enExample) |
| CN (1) | CN105492454B (enExample) |
| AU (1) | AU2014289342B2 (enExample) |
| BR (1) | BR112016000210A2 (enExample) |
| CA (1) | CA2917365A1 (enExample) |
| HK (1) | HK1224300A1 (enExample) |
| IL (1) | IL243452B (enExample) |
| MX (1) | MX2016000099A (enExample) |
| RU (1) | RU2016103771A (enExample) |
| SG (1) | SG11201600042YA (enExample) |
| WO (1) | WO2015004041A1 (enExample) |
| ZA (1) | ZA201600136B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11160855B2 (en) | 2014-01-21 | 2021-11-02 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
| JP6622804B2 (ja) * | 2014-12-12 | 2019-12-18 | マックス プランク ゲゼルシャフト ツゥアー フェデルゥン デル ヴィッセンシャフテン エー フォー | ストレプトコッカス ニューモニアエ（Ｓｔｒｅｐｔｏｃｏｃｃｕｓ ｐｎｅｕｍｏｎｉａｅ）血清型４に対するワクチン |
| CN109311924B (zh) * | 2016-04-14 | 2020-04-17 | 马克斯·普朗克科学促进学会 | 针对肺炎链球菌3型的疫苗的改善的制备 |
| CN111183472A (zh) | 2017-07-17 | 2020-05-19 | 3M创新有限公司 | 弯曲限制膜 |
| GB201711635D0 (en) | 2017-07-19 | 2017-08-30 | Glaxosmithkline Biologicals Sa | Immunogenic composition |
| JP7551618B2 (ja) | 2018-12-12 | 2024-09-17 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | Ｏ－結合型グリコシル化のための修飾キャリアタンパク質 |
| IL305675A (en) * | 2021-03-19 | 2023-11-01 | Mitochondria Emotion Inc | Cyclopropane analogues of n-(trans-4-hydroxycyclohexyl)-6-phenylhexanamide and related compounds |
| JP7714690B2 (ja) | 2021-05-28 | 2025-07-29 | ファイザー・インク | コンジュゲートさせた莢膜糖抗原を含む免疫原性組成物およびその使用 |
| EP4622665A2 (en) | 2022-11-22 | 2025-10-01 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
| TW202527906A (zh) | 2023-09-14 | 2025-07-16 | 美商輝瑞股份有限公司 | 包含經結合之肺炎鏈球菌莢膜醣抗原之佐劑化致免疫性組成物及其用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5153312A (en) * | 1990-09-28 | 1992-10-06 | American Cyanamid Company | Oligosaccharide conjugate vaccines |
| CA2059692C (en) * | 1991-01-28 | 2004-11-16 | Peter J. Kniskern | Pneumoccoccal polysaccharide conjugate vaccine |
| EP1946769B1 (en) * | 2000-06-29 | 2012-05-30 | SmithKline Beecham Biologicals S.A. | Multivalent vaccine composition with reduced dose of Haemophilus influenzae type B |
| WO2005046722A2 (en) | 2003-11-05 | 2005-05-26 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Carbohydrate antigen-nanoparticle conjugates and uses thereof as antimetastatic agents in treating cancer |
| PL1885734T3 (pl) * | 2005-05-06 | 2015-08-31 | Novartis Ag | Immunogeny dla szczepionek przeciwko Meningitidis-A |
| CA2797052A1 (en) * | 2010-04-23 | 2011-10-27 | Ancora Pharmaceuticals Inc. | Synthetic oligosaccharides for staphyloccocus vaccine |
| WO2011137181A1 (en) * | 2010-04-27 | 2011-11-03 | Ancora Pharmaceuticals Inc. | Synthetic oligosaccharides for moraxella vaccine |
-
2014
- 2014-07-07 JP JP2016524767A patent/JP6416249B2/ja active Active
- 2014-07-07 CA CA2917365A patent/CA2917365A1/en not_active Abandoned
- 2014-07-07 RU RU2016103771A patent/RU2016103771A/ru not_active Application Discontinuation
- 2014-07-07 US US14/903,118 patent/US10328141B2/en active Active
- 2014-07-07 BR BR112016000210A patent/BR112016000210A2/pt not_active Application Discontinuation
- 2014-07-07 AU AU2014289342A patent/AU2014289342B2/en active Active
- 2014-07-07 KR KR1020167003282A patent/KR102250099B1/ko active Active
- 2014-07-07 CN CN201480046993.4A patent/CN105492454B/zh active Active
- 2014-07-07 HK HK16112653.5A patent/HK1224300A1/zh unknown
- 2014-07-07 WO PCT/EP2014/064407 patent/WO2015004041A1/en not_active Ceased
- 2014-07-07 SG SG11201600042YA patent/SG11201600042YA/en unknown
- 2014-07-07 EP EP14744787.4A patent/EP3019513B1/en active Active
- 2014-07-07 MX MX2016000099A patent/MX2016000099A/es unknown
-
2016
- 2016-01-03 IL IL243452A patent/IL243452B/en active IP Right Grant
- 2016-01-07 ZA ZA2016/00136A patent/ZA201600136B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR102250099B1 (ko) | 2021-05-10 |
| JP6416249B2 (ja) | 2018-10-31 |
| US20160346374A1 (en) | 2016-12-01 |
| JP2016526564A (ja) | 2016-09-05 |
| ZA201600136B (en) | 2017-04-26 |
| SG11201600042YA (en) | 2016-02-26 |
| BR112016000210A2 (pt) | 2017-08-22 |
| US10328141B2 (en) | 2019-06-25 |
| WO2015004041A1 (en) | 2015-01-15 |
| EP3019513B1 (en) | 2018-01-17 |
| AU2014289342B2 (en) | 2018-05-31 |
| AU2014289342A1 (en) | 2016-01-28 |
| HK1224300A1 (zh) | 2017-08-18 |
| IL243452B (en) | 2019-02-28 |
| CN105492454B (zh) | 2019-09-27 |
| KR20160029844A (ko) | 2016-03-15 |
| RU2016103771A (ru) | 2017-08-11 |
| EP3019513A1 (en) | 2016-05-18 |
| CN105492454A (zh) | 2016-04-13 |
| CA2917365A1 (en) | 2015-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1224300A1 (zh) | 合成针对1型肺炎链球菌的疫苗 | |
| PH12021550318A1 (en) | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | |
| MY192183A (en) | Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof | |
| WO2014180889A8 (en) | Methods and compositions for the treatment of cancer | |
| PH12014502010A1 (en) | Bispecific antibodies against human tweak and human il17 and uses thereof | |
| MX2016003621A (es) | Vacunas sinteticas libres de proteina y peptido contra streptococcus pneumoniae tipo 3. | |
| MX2016008448A (es) | Conjugados de var2csa-farmaco. | |
| MY163871A (en) | Vaccines and compositions against streptococcus pneumoniae | |
| WO2016198170A8 (en) | Vaccines against streptococcus pneumoniae serotype 5 | |
| MX2016008226A (es) | Metodos para el cuidado oral prebiotico usando un sacarido. | |
| BR112015008419A8 (pt) | composição imunogênica, vacina, e, uso de uma composição imunogênica ou de uma vacina | |
| BR112015015864A8 (pt) | composição farmacêutica, e, uso de uma composição farmacêutica | |
| PH12015502747A1 (en) | Novel compounds for the treatment of cancer | |
| TR201905218T4 (tr) | Nörodejenerati̇f hastaliklarin tedavi̇si̇ i̇çi̇n yararli vi̇tanoli̇dler. | |
| PH12019500377A1 (en) | Composition comprising multivalent capsular polysaccharide-transport protein and use thereof | |
| PH12018501205A1 (en) | Synthetic vaccines against streptococcus pneumoniae serotype 2 | |
| WO2014133811A3 (en) | Compounds from invasive salvinias and methods of using the same | |
| WO2015044434A3 (de) | FLUOR-9-METHYL-ß-CARBOLINE | |
| MX2020007246A (es) | Diseño de vacuna integral para el avance de enfermedad comensal. | |
| PH12018500014A1 (en) | Total synthesis of shishijimicin a and analogs thereof | |
| HK1224585A1 (en) | Protein and peptide-free synthetic vaccines against streptococcus pneumoniae type 3 | |
| UA90816U (uk) | Сполука 1,1'-(2''-бром-2''-хлоретеніл)-біс-(6-метилурацил) з потенційними фізіологічними властивостями | |
| CN302378678S (zh) | 药品柜 |